FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kalevi Pyörälä

Research Profile

Disorders

Geographic Areas

Finland

Concepts & Ideas

Chemicals & Drugs

Procedures

Glucose Tolerance Test

Co-author Network

Publications

TOP 3
Feng Ning; Altan Onat; Kalevi Pyörälä; Qing Qiao; Coen D A Stehouwer; Jaakko Tuomilehto; John S Yudkin; Lei Zhang; Jacqueline M Dekker; Tiina Laatikainen
Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range.
Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Zeljko Reiner; Ulrich Keil
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
Feng Ning; Jaakko Tuomilehto; Kalevi Pyörälä; Altan Onat; Stefan Söderberg; Qing Qiao
Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kalevi Pyörälä (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Feng Ning; Altan Onat; Kalevi Pyörälä; Qing Qiao; Coen D A Stehouwer; Jaakko Tuomilehto; John S Yudkin; Lei Zhang; Jacqueline M Dekker; Tiina Laatikainen
Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range.
Cardiovascular diabetology 2012;11():76.
2010: Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Zeljko Reiner; Ulrich Keil
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2010;17(5):530-40.
2010: Feng Ning; Jaakko Tuomilehto; Kalevi Pyörälä; Altan Onat; Stefan Söderberg; Qing Qiao
Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.
Diabetes care 2010;33(10):2211-6.
2010: X H Zhou; Qing Qiao; Björn Zethelius; Kalevi Pyörälä; Stefan Söderberg; A Pajak; C D A Stehouwer; R J Heine; Pekka Jousilahti; Giacomo Ruotolo; P M Nilsson; G Calori; Jaakko Tuomilehto
Diabetes, prediabetes and cancer mortality.
Diabetologia 2010;53(9):1867-76.
2009: Marjukka Hyvärinen; Jaakko Tuomilehto; Markku Mähönen; Coen D A Stehouwer; Kalevi Pyörälä; Björn Zethelius; Qing Qiao
Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.
Stroke; a journal of cerebral circulation 2009;40(5):1633-7.
2009: Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(2):121-37.
2009: Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
Lancet 2009;373(9667):929-40.
2009: Marjukka Hyvärinen; Qing Qiao; Jaakko Tuomilehto; Tiina Laatikainen; Robert J Heine; Coen D A Stehouwer; K George M M Alberti; Kalevi Pyörälä; Björn Zethelius; Birgitta Stegmayr
Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria.
Diabetes care 2009;32(2):348-54.
2008: Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
Diabetes care 2008;31(4):714-9.
2008: Harry Hemingway; Claudia Langenberg; Jacqueline Damant; Chris Frost; Kalevi Pyörälä; Elizabeth Barrett-Connor
Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries.
Circulation 2008;117(12):1526-36.
2008: Heli Koukkunen; Veikko Salomaa; Seppo Lehto; Matti Ketonen; Pirjo Immonen-Räihä; Aapo Lehtonen; Aki Havulinna; Y Antero Kesäniemi; Kalevi Pyörälä
Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.
The American journal of geriatric cardiology 2008;17(2):78-86.
2007: Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Diabetes care 2007;30(2):292-9.
2006: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Aapo Lehtonen; Jorma Torppa; Kari Kuulasmaa; Y Antero Kesäniemi; Kalevi Pyörälä
The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study.
European heart journal 2006;27(20):2394-9.
2006: Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.
Diabetologia 2006;49(1):56-65.
2005: Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.
Diabetes care 2005;28(12):2901-7.
2005: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Kari Kuulasmaa; Pertti Palomäki; J Mustonen; A Lehtonen; Matti Arstila; Tapio Vuorenmaa; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä; Veikko Salomaa
Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study.
Diabetologia 2005;48(12):2519-24.
2005: Veikko Salomaa; Heli Koukkunen; Matti Ketonen; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Juha Mustonen; Seppo Lehto; Jorma Torppa; Aapo Lehtonen; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
A new definition for myocardial infarction: what difference does it make?
European heart journal 2005;26(17):1719-25.
2005: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Markku Mähönen; Matti Niemelä; Kari Kuulasmaa; Pertti Palomäki; Juha Mustonen; Aapo Lehtonen; Matti Arstila; Tapio Vuorenmaa; Seppo Lehto; Heikki Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä; Veikko Salomaa
The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2005;12(2):132-7.
2004: Auni Juutilainen; Saara Kortelainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
Diabetes care 2004;27(12):2898-904.
2004: Terje R Pedersen; Anders G Olsson; Ole Faergeman; John Kjekshus; Hans Wedel; Kåre Berg; Lars Wilhelmsen; Torben Haghfelt; Gudmundur Thorgeirsson; Kalevi Pyörälä; Tatu A Miettinen; Bjørn Christophersen; Jonathan A Tobert; Thomas A Musliner; Thomas J Cook
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
Atherosclerosis. Supplements 2004;5(3):99-106.
2004: Timo E Strandberg; Kalevi Pyörälä; Thomas J Cook; Lars Wilhelmsen; Ole Faergeman; Gudmundur Thorgeirsson; Terje R Pedersen; John Kjekshus
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
Lancet 2004;364(9436):771-7.
2004: Kalevi Pyörälä; Seppo Lehto; D De Bacquer; J De Sutter; S Sans; U Keil; D Wood; G De Backer
Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.
Diabetologia 2004;47(7):1257-65.
2004: Kalevi Pyörälä; Christie M Ballantyne; Barry Gumbiner; Michael W Lee; Arvind Shah; Michael J Davies; Yale B Mitchel; Terje R Pedersen; John Kjekshus
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
Diabetes care 2004;27(7):1735-40.
2004: Heli Koukkunen; Kalevi Pyörälä; Matti O Halinen
Low-risk patients with chest pain and without evidence of myocardial infarction may be safely discharged from emergency department.
European heart journal 2004;25(4):329-34.
2003: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Tapani Jerkkola; Päivi Kärjä-Koskenkari; Markku Mähönen; M Niemelä; Kari Kuulasmaa; Pertti Palomäki; J Mustonen; Matti Arstila; Tapio Vuorenmaa; A Lehtonen; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study.
Circulation 2003;108(6):691-6.
2003: Arja T Erkkilä; Seppo Lehto; Kalevi Pyörälä; M I J Uusitupa
n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.
The American journal of clinical nutrition 2003;78(1):65-71.
2003: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Tapani Jerkkola; Päivi Kärjä-Koskenkari; Markku Mähönen; M Niemelä; Kari Kuulasmaa; Pertti Palomäki; Matti Arstila; Tapio Vuorenmaa; Aapo Lehtonen; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
Trends in coronary events in Finland during 1983-1997. The FINAMI study.
European heart journal 2003;24(4):311-9.
2003: Maarit Viik-Kajander; Elena Moltchanova; Veikko Salomaa; Jaakko Tuomilehto; Matti Ketonen; Pertti Palomäki; Heikki Miettinen; Kalevi Pyörälä; Marjatta Karvonen
Geographical variation in the incidence of acute myocardial infarction in eastern Finland--a Bayesian perspective.
Annals of medicine 2003;35(1):43-50.
2002: Karri Penttilä; Heli Koukkunen; Matti Halinen; Tapio Rantanen; Kalevi Pyörälä; Kari Punnonen; Ilkka Penttilä
Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain.
Clinical biochemistry 2002;35(8):647-53.
2002: Qing Qiao; Kalevi Pyörälä; M Pyörälä; Aulikki Nissinen; Jaana Lindström; R Tilvis; Jaakko Tuomilehto
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.
European heart journal 2002;23(16):1267-75.
2002: Karri Penttilä; Heli Koukkunen; Matti Halinen; Kari Punnonen; Kalevi Pyörälä; Tapio Rantanen; Ilkka Penttilä
Serum and plasma as alternative sample types in analysis of cardiac markers in the clinical routine.
Scandinavian journal of clinical and laboratory investigation 2002;62(7):553-60.
2001: Heli Koukkunen; Karri Penttilä; A Kemppainen; Ilkka Penttilä; Matti Halinen; Tapio Rantanen; Kalevi Pyörälä
Ruling out myocardial infarction with troponin T and creatine kinase MB mass: diagnostic and prognostic aspects.
Scandinavian cardiovascular journal : SCJ 2001;35(5):302-6.
2001: Heli Koukkunen; Karri Penttilä; A Kemppainen; Ilkka Penttilä; Matti Halinen; Tapio Rantanen; Kalevi Pyörälä
Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria.
The American journal of cardiology 2001;88(7):727-31.
2001: Veikko Salomaa; H Miettinen; M Niemelä; Matti Ketonen; Markku Mähönen; Pirjo Immonen-Räihä; Seppo Lehto; Tapio Vuorenmaa; Seppo Koskinen; Pertti Palomäki; H Mustaniemi; E Kaarsalo; Matti Arstila; Jorma Torppa; Kari Kuulasmaa; P Puska; Kalevi Pyörälä; Jaakko Tuomilehto
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study.
Journal of epidemiology and community health 2001;55(7):475-82.
2001: P J Schreiner; M Niemelä; H Miettinen; Markku Mähönen; Matti Ketonen; Pirjo Immonen-Räihä; Seppo Lehto; Tapio Vuorenmaa; Pertti Palomäki; H Mustaniemi; E Kaarsalo; Matti Arstila; Jorma Torppa; P Puska; Jaakko Tuomilehto; Kalevi Pyörälä; Veikko Salomaa
Gender differences in recurrent coronary events; the FINMONICA MI register.
European heart journal 2001;22(9):762-8.
2001: Heli Koukkunen; Karri Penttilä; A Kemppainen; Matti Halinen; I Penttila; Tapio Rantanen; Kalevi Pyörälä
C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.
Annals of medicine 2001;33(1):37-47.
2000: Seppo Lehto; Heli Koukkunen; J Hintikka; H Viinamäki; M Laakso; Kalevi Pyörälä
Depression after coronary heart disease events.
Scandinavian cardiovascular journal : SCJ 2000;34(6):580-3.
2000: M Pyörälä; H Miettinen; Markku Laakso; Kalevi Pyörälä
Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study.
Diabetes care 2000;23(8):1097-102.
2000: Terje R Pedersen; Lars Wilhelmsen; Ole Faergeman; Timo E Strandberg; Gudmundur Thorgeirsson; L Troedsson; J Kristianson; Kåre Berg; Thomas J Cook; Torben Haghfelt; John Kjekshus; Tatu A Miettinen; Anders G Olsson; Kalevi Pyörälä; Hans Wedel
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
The American journal of cardiology 2000;86(3):257-62.
2000: Veikko Salomaa; M Niemelä; H Miettinen; Matti Ketonen; Pirjo Immonen-Räihä; Seppo Koskinen; Markku Mähönen; Seppo Lehto; Tapio Vuorenmaa; Pertti Palomäki; H Mustaniemi; E Kaarsalo; Matti Arstila; Jorma Torppa; Kari Kuulasmaa; P Puska; Kalevi Pyörälä; Jaakko Tuomilehto
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study.
Circulation 2000;101(16):1913-8.
2000: Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes.
Diabetologia 2000;43(2):148-55.
2000: M Pyörälä; H Miettinen; P Halonen; Markku Laakso; Kalevi Pyörälä
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):538-44.
1999: Steven M Haffner; Charles M Alexander; Thomas J Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1999;159(22):2661-7.
1999: William H Herman; Charles M Alexander; John R Cook; Steve J Boccuzzi; Thomas A Musliner; Terje R Pedersen; John Kjekshus; Kalevi Pyörälä
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
Diabetes care 1999;22(11):1771-8.
1999: Arja T Erkkilä; Essi S Sarkkinen; Seppo Lehto; Kalevi Pyörälä; M I J Uusitupa
Diet in relation to socioeconomic status in patients with coronary heart disease.
European journal of clinical nutrition 1999;53(8):662-8.
1999: P Lempiäinen; Leena Mykkänen; Kalevi Pyörälä; Markku Laakso; Johanna Kuusisto
Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.
Circulation 1999;100(2):123-8.
1999: Arja T Erkkilä; Essi S Sarkkinen; Seppo Lehto; Kalevi Pyörälä; M I J Uusitupa
Dietary associates of serum total, LDL, and HDL cholesterol and triglycerides in patients with coronary heart disease.
Preventive medicine 1999;28(6):558-65.
1999: Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):1014-9.
1999: Kalevi Pyörälä
[Assessing the individual risk of atherosclerosis].
Duodecim; lääketieteellinen aikakauskirja 1999;115(10):1129-34.
1999: Karri Penttilä; Heli Koukkunen; A Kemppainen; Matti Halinen; Tapio Rantanen; Kalevi Pyörälä; Ilkka Penttilä
Myoglobin, creatine kinase MB, troponin T, and troponin I - rapid bedside assays in patients with acute chest pain.
International journal of clinical & laboratory research 1999;29(2):93-101.
1999: Päivi Kekäläinen; H Sarlund; Kalevi Pyörälä; Markku Laakso
Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
Diabetes care 1999;22(1):86-92.
1998: Ole Faergeman; John Kjekshus; T Cook; Kalevi Pyörälä; Lars Wilhelmsen; Gudmundur Thorgeirsson; Terje R Pedersen
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)
European heart journal 1998;19(10):1531-7.
1998: Heli Koukkunen; Karri Penttilä; A Kemppainen; Matti Halinen; Ilkka Penttilä; Tapio Rantanen; Kalevi Pyörälä
Troponin T and creatinine kinase isoenzyme MB mass in the diagnosis of myocardial infarction.
Annals of medicine 1998;30(5):488-96.
1998: M Pyörälä; H Miettinen; Markku Laakso; Kalevi Pyörälä
Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.
Stroke; a journal of cerebral circulation 1998;29(9):1860-6.
1998: M Pyörälä; H Miettinen; Markku Laakso; Kalevi Pyörälä
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.
Circulation 1998;98(5):398-404.
1998: Terje R Pedersen; Anders G Olsson; Ole Faergeman; John Kjekshus; Hans Wedel; Kåre Berg; Lars Wilhelmsen; Torben Haghfelt; Gudmundur Thorgeirsson; Kalevi Pyörälä; Tatu A Miettinen; B Christophersen; Jonathan A Tobert; Thomas A Musliner; Thomas J Cook
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
Circulation 1998;97(15):1453-60.
1998: Arja T Erkkilä; Essi S Sarkkinen; Heli Koukkunen; A Kemppainen; Seppo Lehto; Kalevi Pyörälä; M I J Uusitupa
Concordance of diet with the recommended cholesterol lowering diet in patients with coronary heart disease.
European journal of clinical nutrition 1998;52(4):279-85.
1998: Beverley Balkau; M Shipley; R J Jarrett; Kalevi Pyörälä; M Pyörälä; Anne Forhan; Eveline Eschwège
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.
Diabetes care 1998;21(3):360-7.
1998: Terje R Pedersen; John Kjekshus; Kalevi Pyörälä; Anders G Olsson; Thomas J Cook; Thomas A Musliner; Jonathan A Tobert; Torben Haghfelt
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S).
The American journal of cardiology 1998;81(3):333-5.
1998: H Miettinen; Seppo Lehto; V Salomaa; Markku Mähönen; M Niemelä; Steven M Haffner; Kalevi Pyörälä; Jaakko Tuomilehto
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.
Diabetes care 1998;21(1):69-75.
1997: Tatu A Miettinen; Kalevi Pyörälä; Anders G Olsson; Thomas A Musliner; Thomas J Cook; Ole Faergeman; Kåre Berg; T Pedersen; John Kjekshus
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
Circulation 1997;96(12):4211-8.
1997: Beverley Balkau; M Pyörälä; M Shipley; Anne Forhan; J Jarrett; Eveline Eschwège; Kalevi Pyörälä
Non-cardiovascular disease mortality and diabetes mellitus.
Lancet 1997;350(9092):1680.
1997: John Kjekshus; Terje R Pedersen; Anders G Olsson; Ole Faergeman; Kalevi Pyörälä
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
Journal of cardiac failure 1997;3(4):249-54.
1997: Timo E Strandberg; S Lehto; Kalevi Pyörälä; A Kesäniemi; H Oksa
Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland.
European heart journal 1997;18(11):1725-7.
1996: V Salomaa; H Miettinen; Kari Kuulasmaa; M Niemelä; Matti Ketonen; Tapio Vuorenmaa; Seppo Lehto; Pertti Palomäki; Markku Mähönen; Pirjo Immonen-Räihä; Matti Arstila; E Kaarsalo; H Mustaniemi; Jorma Torppa; Jaakko Tuomilehto; P Puska; Kalevi Pyörälä
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study.
Circulation 1996;94(12):3130-7.
1996: H Miettinen; Steven M Haffner; Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.
Stroke; a journal of cerebral circulation 1996;27(11):2033-9.
1996: Terje R Pedersen; Kåre Berg; Thomas J Cook; Ole Faergeman; Torben Haghfelt; John Kjekshus; Tatu A Miettinen; Thomas A Musliner; Anders G Olsson; Kalevi Pyörälä; Gudmundur Thorgeirsson; Jonathan A Tobert; H Wedel; Lars Wilhelmsen
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
Archives of internal medicine 1996;156(18):2085-92.
1996: Kalevi Pyörälä; G Steiner
Will correction of dyslipoproteinaemia reduce coronary heart disease risk in patients with non-insulin-dependent diabetes? Need for trial evidence.
Annals of medicine 1996;28(4):357-62.
1996: P Kekäläinen; H Sarlund; Kalevi Pyörälä; Markku Laakso
Family history of coronary heart disease is a stronger predictor of coronary heart disease morbidity and mortality than family history of non-insulin dependent diabetes mellitus.
Atherosclerosis 1996;123(1-2):203-13.
1996: Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Risk factors predicting lower extremity amputations in patients with NIDDM.
Diabetes care 1996;19(6):607-12.
1996: Terje R Pedersen; John Kjekshus; Kåre Berg; Anders G Olsson; Lars Wilhelmsen; H Wedel; Kalevi Pyörälä; Tatu A Miettinen; Torben Haghfelt; Ole Faergeman; Gudmundur Thorgeirsson; B Jönsson; J S Schwartz
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.
Circulation 1996;93(10):1796-802.
1996: H Miettinen; Seppo Lehto; P Saikku; Steven M Haffner; T Rönnemaa; Kalevi Pyörälä; M Laakso
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.
European heart journal 1996;17(5):682-8.
1996: Seppo Lehto; T Rönnemaa; Kalevi Pyörälä; Markku Laakso
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes.
Stroke; a journal of cerebral circulation 1996;27(1):63-8.
1996: J Hartikainen; Jyrki Kuikka; M Mäntysaari; Esko Länsimies; Kalevi Pyörälä
Sympathetic reinnervation after acute myocardial infarction.
The American journal of cardiology 1996;77(1):5-9.
1995: J Hartikainen; M Mäntysaari; Hanna Mussalo; Kari U O Tahvanainen; Esko Länsimies; Kalevi Pyörälä
Good exercise capacity at hospital discharge predicts recovery of baroreflex sensitivity after myocardial infarction.
European heart journal 1995;16(11):1520-5.
1995: Kalevi Pyörälä; G de Backer; I Graham; P Poole-Wilson; D Wood
[Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
Archives des maladies du coeur et des vaisseaux 1995;88(10 Suppl):1493-542.
1995: Leena Mykkänen; Steven M Haffner; Johanna Kuusisto; Kalevi Pyörälä; C N Hales; Markku Laakso
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.
Diabetologia 1995;38(10):1176-82.
1995: Markku Mähönen; H Miettinen; Kalevi Pyörälä; Anu Molarius; Veikko Salomaa; Kari Kuulasmaa
Hospital discharge register data in the assessment of trends in acute myocardial infarction. FINMONICA AMI Register Study Team.
Annals of medicine 1995;27(5):547-54.
1995: Tuomo Hänninen; Merja Hallikainen; Keijo Koivisto; Eeva-Liisa Helkala; K J Reinikainen; Hilkka Soininen; L Mykkänen; Markku Laakso; Kalevi Pyörälä; PJ Riekkinen
A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia.
Journal of the American Geriatrics Society 1995;43(9):1007-15.
1995: J Hartikainen; F Fyhrquist; Kari U O Tahvanainen; Esko Länsimies; Kalevi Pyörälä
Baroreflex sensitivity and neurohormonal activation in patients with acute myocardial infarction.
British heart journal 1995;74(1):21-6.
1995: M Mäntysaari; Jyrki Kuikka; J Hartikainen; J Mustonen; Hanna Mussalo; Kari U O Tahvanainen; Esko Länsimies; Matti Uusitupa; Kalevi Pyörälä
Myocardial sympathetic nervous dysfunction detected with iodine-123-MIBG is associated with low heart rate variability after myocardial infarction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(6):956-61.
1995: Markku Laakso; T Rönnemaa; Seppo Lehto; P Puukka; V Kallio; Kalevi Pyörälä
Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?
Diabetologia 1995;38(4):487-93.
1995: Keijo Koivisto; K J Reinikainen; Tuomo Hänninen; Matti Vanhanen; Eeva-Liisa Helkala; L Mykkänen; Markku Laakso; Kalevi Pyörälä; PJ Riekkinen
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland.
Neurology 1995;45(4):741-7.
1995: Johanna Kuusisto; L Mykkänen; Kalevi Pyörälä; Markku Laakso
Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.
Circulation 1995;91(3):831-7.
1994: J Hartikainen; M Mäntysaari; Hanna Mussalo; Kari U O Tahvanainen; Esko Länsimies; Kalevi Pyörälä
Baroreflex sensitivity in men with recent myocardial infarction; impact of age.
European heart journal 1994;15(11):1512-9.
1994: J Hartikainen; M Mäntysaari; Jyrki Kuikka; Esko Länsimies; Kalevi Pyörälä
Extent of cardiac autonomic denervation in relation to angina on exercise test in patients with recent acute myocardial infarction.
The American journal of cardiology 1994;74(8):760-3.
1994: Kalevi Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
Atherosclerosis 1994;110(2):121-61.
1994: Kalevi Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
European heart journal 1994;15(10):1300-31.
1994: Johanna Kuusisto; Keijo Koivisto; K Kervinen; Leena Mykkänen; Eeva-Liisa Helkala; Matti Vanhanen; Tuomo Hänninen; Kalevi Pyörälä; Y A Kesäniemi; PJ Riekkinen
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.
BMJ (Clinical research ed.) 1994;309(6955):636-8.
1994: Seppo Lehto; Kalevi Pyörälä; H Miettinen; T Rönnemaa; Pertti Palomäki; Jaakko Tuomilehto; M Laakso
Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus.
Journal of internal medicine 1994;236(3):291-7.
1994: J N Mustonen; M I J Uusitupa; Markku Laakso; Esko Vanninen; Esko Länsimies; Jyrki T Kuikka; Kalevi Pyörälä
Left ventricular systolic function in middle-aged patients with diabetes mellitus.
The American journal of cardiology 1994;73(16):1202-8.
1994: Johanna Kuusisto; L Mykkänen; Kalevi Pyörälä; Markku Laakso
Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects.
Stroke; a journal of cerebral circulation 1994;25(6):1157-64.
1994: Pertti Palomäki; H Miettinen; H Mustaniemi; Seppo Lehto; Kalevi Pyörälä; Markku Mähönen; Jaakko Tuomilehto
Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis.
Journal of clinical epidemiology 1994;47(6):659-66.
1994: Leena Mykkänen; Johanna Kuusisto; Steven M Haffner; Kalevi Pyörälä; Markku Laakso
Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):518-26.
1994: Tuomo Hänninen; K J Reinikainen; Eeva-Liisa Helkala; Keijo Koivisto; L Mykkänen; Markku Laakso; Kalevi Pyörälä; PJ Riekkinen
Subjective memory complaints and personality traits in normal elderly subjects.
Journal of the American Geriatrics Society 1994;42(1):1-4.
1993: M I J Uusitupa; Leo Niskanen; O Siitonen; E Voutilainen; Kalevi Pyörälä
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
Diabetologia 1993;36(11):1175-84.
1993: Johanna Kuusisto; Keijo Koivisto; Leena Mykkänen; Eeva-Liisa Helkala; Matti Vanhanen; Tuomo Hänninen; Kalevi Pyörälä; PJ Riekkinen; Markku Laakso
Essential hypertension and cognitive function. The role of hyperinsulinemia.
Hypertension 1993;22(5):771-9.
1993: Markku Laakso; Seppo Lehto; I Penttilä; Kalevi Pyörälä
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
Circulation 1993;88(4 Pt 1):1421-30.
1993: Leena Mykkänen; Johanna Kuusisto; Kalevi Pyörälä; Markku Laakso
Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.
Diabetologia 1993;36(6):553-9.
1993: Leena Mykkänen; Markku Laakso; Kalevi Pyörälä
High plasma insulin level associated with coronary heart disease in the elderly.
American journal of epidemiology 1993;137(11):1190-202.
1993: J Hartikainen; I Tarkiainen; Kari U O Tahvanainen; M Mäntysaari; Esko Länsimies; Kalevi Pyörälä
Circadian variation of cardiac autonomic regulation during 24-h bed rest.
Clinical physiology (Oxford, England) 1993;13(2):185-96.
1993: Matti Uusitupa; J Laitinen; O Siitonen; Esko Vanninen; Kalevi Pyörälä
The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes.
Diabetes research and clinical practice 1993;19(3):227-38.
1993: Seppo Lehto; Pertti Palomäki; H Miettinen; I Penttilä; Veikko Salomaa; Jaakko Tuomilehto; M Jauhiainen; Kalevi Pyörälä
Serum cholesterol and high density lipoprotein cholesterol distributions in patients with acute myocardial infarction and in the general population of Kuopio province, eastern Finland.
Journal of internal medicine 1993;233(2):179-85.
1993: O I Siitonen; L K Niskanen; Markku Laakso; J T Siitonen; Kalevi Pyörälä
Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland.
Diabetes care 1993;16(1):16-20.
1992: T Ebeling; P Farin; Kalevi Pyörälä
Ultrasonography in the detection of Achilles tendon xanthomata in heterozygous familial hypercholesterolemia.
Atherosclerosis 1992;97(2-3):217-28.
1992: Esko Vanninen; Matti Uusitupa; Jouko Remes; O Siitonen; J Laitinen; Esko Länsimies; Kalevi Pyörälä
Relationship between hyperglycaemia and aerobic power in men with newly diagnosed type 2 (non insulin-dependent) diabetes.
Clinical physiology (Oxford, England) 1992;12(6):667-77.
1992: Leena Mykkänen; Markku Laakso; Kalevi Pyörälä
Asymptomatic hyperglycemia and atherosclerotic vascular disease in the elderly.
Diabetes care 1992;15(8):1020-30.
1992: J Mustonen; Matti Uusitupa; Esko Länsimies; P Vainio; M Laakso; Kalevi Pyörälä
Autonomic nervous function and its relationship to cardiac performance in middle-aged diabetic patients without clinically evident cardiovascular disease.
Journal of internal medicine 1992;232(1):65-72.
1992: Keijo Koivisto; Eeva-Liisa Helkala; K J Reinikainen; Tuomo Hänninen; L Mykkänen; Markku Laakso; Kalevi Pyörälä; PJ Riekkinen
Population-based dementia screening program in Kuopio: the effect of education, age, and sex on brief neuropsychological tests.
Journal of geriatric psychiatry and neurology 1992;5(3):162-71.
1992: M I J Uusitupa; L Mykkänen; O Siitonen; Markku Laakso; H Sarlund; P Kolehmainen; T Räsänen; J Kumpulainen; Kalevi Pyörälä
Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels.
The British journal of nutrition 1992;68(1):209-16.
1992: M I J Uusitupa; Tatu A Miettinen; P Happonen; T Ebeling; Hannu Turtola; E Voutilainen; Kalevi Pyörälä
Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(7):807-13.
1992: H Sarlund; Kalevi Pyörälä; I Penttilä; Markku Laakso
Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(6):657-63.
1992: Jouko Remes; A Reunanen; A Aromaa; Kalevi Pyörälä
Incidence of heart failure in eastern Finland: a population-based surveillance study.
European heart journal 1992;13(5):588-93.
1992: T Ebeling; Hannu Turtola; E Voutilainen; Matti Uusitupa; Kalevi Pyörälä; T Reijonen
Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
Annals of medicine 1992;24(2):121-7.
1992: K Aalto-Setälä; U M Koivisto; Tatu A Miettinen; Helena Gylling; Y A Kesäniemi; Markku Savolainen; Kalevi Pyörälä; T Ebeling; I Mononen; Hannu Turtola
Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland.
Journal of internal medicine 1992;231(3):227-34.
1992: M Leino; Kalevi Pyörälä; Seppo Lehto; Arto Rantala
Lens opacity in patients with hypercholesterolemia and ischaemic heart disease. Electronic lens opacity measurements.
Documenta ophthalmologica. Advances in ophthalmology 1992;80(4):309-15.
1992: Seppo Lehto; Pertti Palomäki; H Miettinen; Veikko Salomaa; Jaakko Tuomilehto; M Jauhiainen; I Penttilä; Kalevi Pyörälä
[Are there differences in lipid distribution between subjects with or without heart infarction?].
Duodecim; lääketieteellinen aikakauskirja 1992;108(1):33-9.
1991: Markku Laakso; A Kesäniemi; K Kervinen; M Jauhiainen; Kalevi Pyörälä
Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
BMJ (Clinical research ed.) 1991;303(6811):1159-62.
1991: Matti Uusitupa; T Ebeling; P Happonen; E Voutilainen; Hannu Turtola; Markku Parviainen; Kalevi Pyörälä
Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
Journal of cardiovascular pharmacology 1991;18(4):496-503.
1991: T Hirvonen; Jouko Remes; J Mustonen; I Tikkanen; M Tenhunen; Kalevi Pyörälä
Effect of enalapril on plasma atrial natriuretic peptide in late recovery phase of acute myocardial infarction.
Annals of medicine 1991;23(3):271-5.
1991: Markku Laakso; H Sarlund; Riitta Salonen; M Suhonen; Kalevi Pyörälä; Jukka T Salonen; P Karhapää
Asymptomatic atherosclerosis and insulin resistance.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(4):1068-76.
1991: Leo Niskanen; M I J Uusitupa; Kalevi Pyörälä
The relationship of hyperinsulinaemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects.
Journal of human hypertension 1991;5(3):155-9.
1991: L Mykkänen; Markku Laakso; I Penttilä; Kalevi Pyörälä
Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly.
Atherosclerosis 1991;88(2-3):153-61.
1991: Markku Laakso; A Reunanen; T Klaukka; Arpo Aromaa; J Maatela; Kalevi Pyörälä
Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987.
American journal of epidemiology 1991;133(9):850-7.
1991: Esko Vanninen; Matti Uusitupa; O Siitonen; J Laitinen; Esko Länsimies; Kalevi Pyörälä
Effect of diet therapy on maximum aerobic power in obese, hyperglycaemic men with recently diagnosed type 2 diabetes.
Scandinavian journal of clinical and laboratory investigation 1991;51(3):289-97.
1991: Hannu Manninen; Jouko Remes; K Partanen; P Tynkkynen; L Mykkänen; M Laakso; Seppo Soimakallio; Kalevi Pyörälä
Evaluation of heart size and pulmonary vasculature. Conventional chest roentgenography and image intensifier photofluorography compared.
Acta radiologica (Stockholm, Sweden : 1987) 1991;32(3):226-31.
1991: Jouko Remes; I Tikkanen; F Fyhrquist; Kalevi Pyörälä
Neuroendocrine activity in untreated heart failure.
British heart journal 1991;65(5):249-55.
1991: Jouko Remes; H Miettinen; A Reunanen; Kalevi Pyörälä
Validity of clinical diagnosis of heart failure in primary health care.
European heart journal 1991;12(3):315-21.
1991: H Sarlund; Markku Laakso; E Voutilainen; I Penttilä; Kalevi Pyörälä
Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
Atherosclerosis 1991;86(1):17-29.
1991: Jyrki T Kuikka; J N Mustonen; M I J Uusitupa; Pentti J Rautio; Esko Vanninen; Markku Laakso; Esko Länsimies; Kalevi Pyörälä
Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin-dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid.
European journal of nuclear medicine 1991;18(7):475-81.
1991: Jouko Remes; Esko Länsimies; Kalevi Pyörälä
Usefulness of M-mode echocardiography in the diagnosis of heart failure.
Cardiology 1991;78(3):267-77.
1991: Jouko Remes; Esko Länsimies; Kalevi Pyörälä
Cardiopulmonary exercise testing has limited value in diagnosing heart failure.
Annals of medicine 1991;23(5):521-7.
1990: Leena Mykkänen; Markku Laakso; Matti Uusitupa; Kalevi Pyörälä
Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes.
Diabetes care 1990;13(11):1099-105.
1990: M I J Uusitupa; Leo Niskanen; O Siitonen; E Voutilainen; Kalevi Pyörälä
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.
Circulation 1990;82(1):27-36.
1990: Leo Niskanen; Matti Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; Kalevi Pyörälä
Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.
Diabetologia 1990;33(4):237-43.
1990: Markku Laakso; Kalevi Pyörälä
Plasma lipids and lipoproteins in diabetes: lessons from population-based studies.
The Journal of diabetic complications 1990;4(2):39-41.
1990: Markku Laakso; M Suhonen; Risto Julkunen; Kalevi Pyörälä
Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study.
Gut 1990;31(3):344-7.
1990: Markku Laakso; Kalevi Pyörälä
Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Metabolism: clinical and experimental 1990;39(2):117-22.
1990: Leo Niskanen; M I J Uusitupa; H Sarlund; O Siitonen; Kalevi Pyörälä
Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.
Diabetes care 1990;13(1):41-8.
1990: Kalevi Pyörälä
Preventive cardiology: a progress report.
Preventive medicine 1990;19(1):78-96.
1990: Kalevi Pyörälä
Diabetes and coronary artery disease: what a coincidence?
Journal of cardiovascular pharmacology 1990;16 Suppl 9():S8-14.
1989: Kalevi Pyörälä
Coronary heart disease in Finland. Towards consensus on strategies for prevention.
Annals of medicine 1989;21(6):405-8.
1989: Markku Laakso; T Rönnemaa; H Sarlund; Kalevi Pyörälä; V Kallio
Factors associated with fasting and postglucagon plasma C-peptide levels in middle-aged insulin-treated diabetic patients.
Diabetes care 1989;12(2):83-8.
1989: M O Halinen; Pertti Palomäki; J Kuikka; Esko Länsimies; H Miettinen; I Penttilä; Kalevi Pyörälä
Effect of early metoprolol injection followed by oral dosage on CK-MB release, and myocardial function in suspected acute myocardial infarction. A double-blind controlled study.
Cardiology 1989;76(3):180-92.
1988: J N Mustonen; M I J Uusitupa; Kari U O Tahvanainen; S Talwar; Markku Laakso; Esko Länsimies; Jyrki T Kuikka; Kalevi Pyörälä
Impaired left ventricular systolic function during exercise in middle-aged insulin-dependent and noninsulin-dependent diabetic subjects without clinically evident cardiovascular disease.
The American journal of cardiology 1988;62(17):1273-9.
1988: Matti Uusitupa; J Mustonen; Markku Laakso; P Vainio; Esko Länsimies; S Talwar; Kalevi Pyörälä
Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease.
Diabetologia 1988;31(11):783-91.
1988: Markku Laakso; Kalevi Pyörälä
Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.
Atherosclerosis 1988;74(1-2):55-63.
1988: J Mustonen; Markku Laakso; Matti Uusitupa; H Sarlund; Kalevi Pyörälä; Pentti J Rautio; Jyrki Kuikka; Esko Länsimies
Improvement of left ventricular function after starting insulin treatment in patients with non-insulin-dependent diabetes.
Diabetes research (Edinburgh, Scotland) 1988;9(1):27-30.
1988: Markku Laakso; T Rönnemaa; Kalevi Pyörälä; V Kallio; P Puukka; I Penttilä
Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland.
Diabetes care 1988;11(6):449-63.
1988: M Uusitupa; J Mustonen; O Siitonen; Kalevi Pyörälä
Quantitative electrocardiographic and vectorcardiographic study on newly-diagnosed non-insulin-dependent diabetic and non-diabetic control subjects.
Cardiology 1988;75(1):1-9.
1988: Markku Laakso; H Sarlund; T Korhonen; E Voutilainen; H Majander; P Hakala; Matti Uusitupa; Kalevi Pyörälä
Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins.
Acta medica Scandinavica 1988;223(1):61-8.
1987: Markku Laakso; H Sarlund; C Ehnholm; E Voutilainen; A Aro; Kalevi Pyörälä
Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Diabetologia 1987;30(9):703-6.
1987: Kalevi Pyörälä
Interpopulation correlations between serum cholesterol level and the occurrence of coronary heart disease.
European heart journal 1987;8 Suppl E():23-30.
1987: O Siitonen; M Uusitupa; Kalevi Pyörälä; Esko Länsimies; E Voutilainen
Aortic calcifications and their relationship to coronary heart disease and cardiovascular risk factors in patients with newly diagnosed non-insulin-dependent diabetes and in nondiabetic subjects.
Cardiology 1987;74(5):335-43.
1987: M Uusitupa; O Siitonen; Kalevi Pyörälä; J Mustonen; E Voutilainen; K Hersio; I Penttilä
Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects.
Diabetes research (Edinburgh, Scotland) 1987;4(1):19-25.
1987: T Korhonen; Matti Uusitupa; A Aro; T Kumpulainen; O Siitonen; E Voutilainen; Kalevi Pyörälä
Efficacy of dietary instructions in newly diagnosed non-insulin-dependent diabetic patients. Comparison of two different patient education regimens.
Acta medica Scandinavica 1987;222(4):323-31.
1986: M Uusitupa; O Siitonen; E Voutilainen; A Aro; K Hersio; Kalevi Pyörälä; I Penttilä; C Ehnholm
Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels.
Diabetes care 1986;9(1):17-22.
1986: Jouko Remes; P Nikander; S Rehnberg; M O Halinen; J Kuikka; Esko Länsimies; Kalevi Pyörälä
Enalapril in chronic heart failure, a double-blind placebo-controlled study.
Annals of clinical research 1986;18(3):124-8.
1985: M Uusitupa; O Siitonen; Kalevi Pyörälä; A Aro; K Hersio; I Penttilä; E Voutilainen
The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes.
Diabetologia 1985;28(9):653-9.
1984: M Uusitupa; J Kumpulainen; E Voutilainen; H Sarlund; K Hersio; Kalevi Pyörälä; P Koivistoinen; J Lehto
[The effect of chromium supplementation on glucose tolerance, insulin response and serum lipids in maturity-onset diabetes].
Duodecim; lääketieteellinen aikakauskirja 1984;100(1):29-34.
1983: M I J Uusitupa; J T Kumpulainen; E Voutilainen; K Hersio; H Sarlund; Kalevi Pyörälä; P E Koivistoinen; J T Lehto
Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics.
The American journal of clinical nutrition 1983;38(3):404-10.
1983: T Korhonen; J K Huttunen; A Aro; M Hentinen; O Ihalainen; H Majander; O Siitonen; Matti Uusitupa; Kalevi Pyörälä
A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes.
Diabetes care 1983;6(3):256-61.
1982: V Rissanen; M Helin; S Rehnberg; T Romppanen; Y Jokinen; H Raunio; Kalevi Pyörälä
In-hospital death from ischaemic heart disease.
Cardiology 1982;69(3):130-41.